1. Platelet function normalization after a prasugrel loading‐dose: time‐dependent effect of platelet supplementation
- Author
-
ZAFAR, MU, SANTOS‐GALLEGO, C, VORCHHEIMER, DA, VILES‐GONZALEZ, JF, ELMARIAH, S, GIANNARELLI, C, SARTORI, S, SMALL, DS, JAKUBOWSKI, JA, FUSTER, V, and BADIMON, JJ
- Subjects
Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Clinical Research ,Hematology ,Cardiovascular ,Acute Coronary Syndrome ,Adult ,Aspirin ,Biotransformation ,Blood Platelets ,Dose-Response Relationship ,Drug ,Drug Administration Schedule ,Female ,Hemostasis ,Humans ,Male ,Piperazines ,Platelet Aggregation ,Platelet Aggregation Inhibitors ,Platelet Count ,Platelet Transfusion ,Prasugrel Hydrochloride ,Prospective Studies ,Thiophenes ,acute coronary syndrome ,antiplatelet ,prasugrel ,thienopyridine ,transfusion ,Cardiorespiratory Medicine and Haematology ,Clinical Sciences ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology ,Clinical sciences - Abstract
BackgroundHemostatic benefits of platelet transfusions in thienopyridine-treated acute coronary syndrome (ACS) patients may be compromised by residual metabolite in circulation.ObjectivesTo estimate the earliest time after a prasugrel loading-dose when added platelets are no longer inhibited by prasugrel's active metabolite.MethodsBaseline platelet reactivity of healthy subjects (n=25, 30 ± 5 years, 68% male) on ASA 325 mg was tested using maximum platelet aggregation (MPA, ADP 20 μm) and VerifyNow(®) P2Y12 and was followed by a 60 mg prasugrel loading-dose. At 2, 6, 12 and 24 h post-dose, fresh concentrated platelets from untreated donors were added ex-vivo to subjects' blood, raising platelet counts by 0% (control), 40%, 60% and 80%. To estimate the earliest time when prasugrel's active metabolite's inhibitory effect on the added platelets ceases, platelet function in supplemented samples was compared across time-points to identify the time when effect of supplementation on platelet function stabilized (i.e. the increase in platelet reactivity was statistically similar to that at the next time-point).ResultsSupplemented samples showed concentration-dependent increases in platelet reactivity vs. respective controls by both MPA and VerifyNow(®) at all assessment time-points. For each supplementation level, platelet reactivity showed a sharp increase from 2 to 6 h but was stable (P=NS) between 6 and 12 h.ConclusionsThe earliest measured time when supplemented platelets were not inhibited by circulating active metabolite of prasugrel was 6 h after a prasugrel loading-dose. These findings may have important implications for prasugrel-treated ACS patients requiring platelet transfusions during surgery.
- Published
- 2013